Home » One Lot of H1N1 Vaccine Recalled for Health Issue
One Lot of H1N1 Vaccine Recalled for Health Issue
November 25, 2009
GlaxoSmithKline (GSK) is recalling one lot of its influenza A (H1N1) vaccine Arepanrix in Canada after a higher-than-expected number of reports of anaphylaxis
in patients given vaccine from that lot compared with other patients.